Role of non-coding sequence variants in cancer (original) (raw)

• Kandoth, C. et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333–339 (2013).
  CAS PubMed PubMed Central Google Scholar
• Easton, D. F. & Eeles, R. A. Genome-wide association studies in cancer. Hum. Mol. Genet. 17, R109–R115 (2008).
  CAS PubMed Google Scholar
• Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012).
  CAS PubMed PubMed Central Google Scholar
• Chen, C. Y., Chang, I. S., Hsiung, C. A. & Wasserman, W. W. On the identification of potential regulatory variants within genome wide association candidate SNP sets. BMC Med. Genomics 7, 34 (2014).
  PubMed PubMed Central Google Scholar
• Akhtar-Zaidi, B. et al. Epigenomic enhancer profiling defines a signature of colon cancer. Science 336, 736–739 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kron, K. J., Bailey, S. D. & Lupien, M. Enhancer alterations in cancer: a source for a cell identity crisis. Genome Med. 6, 77 (2014).
  PubMed PubMed Central Google Scholar
• Prensner, J. R. & Chinnaiyan, A. M. The emergence of lncRNAs in cancer biology. Cancer Discov. 1, 391–407 (2011).
  CAS PubMed PubMed Central Google Scholar
• Iyer, M. K. et al. The landscape of long noncoding RNAs in the human transcriptome. Nat. Genet. 47, 199–208 (2015).
  CAS PubMed PubMed Central Google Scholar
• Stirzaker, C., Taberlay, P. C., Statham, A. L. & Clark, S. J. Mining cancer methylomes: prospects and challenges. Trends Genet. 30, 75–84 (2014).
  CAS PubMed Google Scholar
• The 1000 Genomes Project Consortium. An integrated map of genetic variation from 1,092 human genomes. Nature 491, 56–65 (2012).
• Alexandrov, L. B. et al. Signatures of mutational processes in human cancer. Nature 500, 415–421 (2013).
  CAS PubMed PubMed Central Google Scholar
• Abyzov, A. et al. Somatic copy number mosaicism in human skin revealed by induced pluripotent stem cells. Nature 492, 438–442 (2012).
  CAS PubMed PubMed Central Google Scholar
• De, S. Somatic mosaicism in healthy human tissues. Trends Genet. 27, 217–223 (2011).
  CAS PubMed Google Scholar
• Lawrence, M. S. et al. Mutational heterogeneity in cancer and the search for new cancer-associated genes. Nature 499, 214–218 (2013). Shows how mutational heterogeneity in the genome can lead to false positives during the identification of cancer driver genes.
  CAS PubMed PubMed Central Google Scholar
• Horn, S. et al. TERT promoter mutations in familial and sporadic melanoma. Science 339, 959–961 (2013). One of the first papers showing prevalence of TERT promoter mutations in cancer.
  CAS PubMed Google Scholar
• Daye, Z. J., Li, H. & Wei, Z. A powerful test for multiple rare variants association studies that incorporates sequencing qualities. Nucleic Acids Res. 40, e60 (2012).
  CAS PubMed PubMed Central Google Scholar
• Baca, S. C. et al. Punctuated evolution of prostate cancer genomes. Cell 153, 666–677 (2013).
  CAS PubMed PubMed Central Google Scholar
• Stephens, P. J. et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell 144, 27–40 (2011).
  CAS PubMed PubMed Central Google Scholar
• Holland, A. J. & Cleveland, D. W. Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat. Rev. Mol. Cell Biol. 10, 478–487 (2009).
  CAS PubMed PubMed Central Google Scholar
• Nik-Zainal, S. et al. Mutational processes molding the genomes of 21 breast cancers. Cell 149, 979–993 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wittkopp, P. J. & Kalay, G. _Cis_-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence. Nat. Rev. Genet. 13, 59–69 (2012).
  CAS Google Scholar
• Galas, D. J. & Schmitz, A. DNAse footprinting: a simple method for the detection of protein−DNA binding specificity. Nucleic Acids Res. 5, 3157–3170 (1978).
  CAS PubMed PubMed Central Google Scholar
• Neph, S. et al. An expansive human regulatory lexicon encoded in transcription factor footprints. Nature 489, 83–90 (2012).
  CAS PubMed PubMed Central Google Scholar
• Dunham, I. et al. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012). Discussion of functional annotations from the ENCODE project.
  CAS Google Scholar
• Hughes, J. R. et al. Analysis of hundreds of _cis_-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat. Genet. 46, 205–212 (2014).
  CAS PubMed Google Scholar
• de Laat, W. & Dekker, J. 3C-based technologies to study the shape of the genome. Methods 58, 189–191 (2012).
  CAS PubMed Google Scholar
• Yip, K. Y. et al. Classification of human genomic regions based on experimentally determined binding sites of more than 100 transcription-related factors. Genome Biol. 13, R48 (2012).
  CAS PubMed PubMed Central Google Scholar
• The GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015).
• Gerstein, M. B. et al. Architecture of the human regulatory network derived from ENCODE data. Nature 489, 91–100 (2012).
  CAS PubMed PubMed Central Google Scholar
• Chadwick, L. H. The NIH Roadmap Epigenomics Program data resource. Epigenomics 4, 317–324 (2012).
  CAS PubMed PubMed Central Google Scholar
• Kundaje, A. et al. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
  CAS PubMed PubMed Central Google Scholar
• Shalem, O. et al. Systematic dissection of the sequence determinants of gene 3′ end mediated expression control. PLoS Genet. 11, e1005147 (2015).
  PubMed PubMed Central Google Scholar
• Dvir, S. et al. Deciphering the rules by which 5′-UTR sequences affect protein expression in yeast. Proc. Natl Acad. Sci. USA 110, E2792–E2801 (2013).
  CAS PubMed Google Scholar
• Lappalainen, T. et al. Transcriptome and genome sequencing uncovers functional variation in humans. Nature 501, 506–511 (2013).
  CAS PubMed PubMed Central Google Scholar
• The GTEx Consortium. The Genotype-Tissue Expression (GTEx) project. Nat. Genet. 45, 580–585 (2013).
• Morris, K. V. & Mattick, J. S. The rise of regulatory RNA. Nat. Rev. Genet. 15, 423–437 (2014).
  CAS PubMed PubMed Central Google Scholar
• Guttman, M. & Rinn, J. L. Modular regulatory principles of large non-coding RNAs. Nature 482, 339–346 (2012).
  CAS PubMed PubMed Central Google Scholar
• Zhao, J., Sun, B. K., Erwin, J. A., Song, J. J. & Lee, J. T. Polycomb proteins targeted by a short repeat RNA to the mouse X chromosome. Science 322, 750–756 (2008).
  CAS PubMed PubMed Central Google Scholar
• Rinn, J. L. et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129, 1311–1323 (2007).
  CAS PubMed PubMed Central Google Scholar
• Penny, G. D., Kay, G. F., Sheardown, S. A., Rastan, S. & Brockdorff, N. Requirement for Xist in X chromosome inactivation. Nature 379, 131–137 (1996).
  CAS PubMed Google Scholar
• Schmitz, K. M., Mayer, C., Postepska, A. & Grummt, I. Interaction of noncoding RNA with the rDNA promoter mediates recruitment of DNMT3b and silencing of rRNA genes. Genes Dev. 24, 2264–2269 (2010).
  CAS PubMed PubMed Central Google Scholar
• Zhang, Z. et al. PseudoPipe: an automated pseudogene identification pipeline. Bioinformatics 22, 1437–1439 (2006).
  CAS PubMed Google Scholar
• Khurana, E. et al. Segmental duplications in the human genome reveal details of pseudogene formation. Nucleic Acids Res. 38, 6997–7007 (2010).
  CAS PubMed PubMed Central Google Scholar
• Sasidharan, R. & Gerstein, M. Genomics: protein fossils live on as RNA. Nature 453, 729–731 (2008).
  CAS PubMed Google Scholar
• Tam, O. H. et al. Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature 453, 534–538 (2008).
  CAS PubMed PubMed Central Google Scholar
• Loots, G. G. et al. Identification of a coordinate regulator of interleukins 4, 13, and 5 by cross-species sequence comparisons. Science 288, 136–140 (2000).
  CAS PubMed Google Scholar
• Pennacchio, L. A. & Rubin, E. M. Genomic strategies to identify mammalian regulatory sequences. Nat. Rev. Genet. 2, 100–109 (2001).
  CAS PubMed Google Scholar
• Waterston, R. H. et al. Initial sequencing and comparative analysis of the mouse genome. Nature 420, 520–562 (2002).
  CAS PubMed Google Scholar
• Gibbs, R. A. et al. Genome sequence of the Brown Norway rat yields insights into mammalian evolution. Nature 428, 493–521 (2004).
  CAS PubMed Google Scholar
• Lindblad-Toh, K. et al. Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 438, 803–819 (2005).
  CAS PubMed Google Scholar
• Bejerano, G. et al. Ultraconserved elements in the human genome. Science 304, 1321–1325 (2004).
  CAS PubMed Google Scholar
• Peng, J. C., Shen, J. & Ran, Z. H. Transcribed ultraconserved region in human cancers. RNA Biol. 10, 1771–1777 (2013).
  CAS PubMed PubMed Central Google Scholar
• Calin, G. A. et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell 12, 215–229 (2007).
  CAS PubMed Google Scholar
• Khurana, E. et al. Integrative annotation of variants from 1092 humans: application to cancer genomics. Science 342, 1235587 (2013). One of the first methods for genome-wide identification of non-coding candidate cancer drivers.
  PubMed PubMed Central Google Scholar
• Katzman, S. et al. Human genome ultraconserved elements are ultraselected. Science 317, 915 (2007).
  CAS PubMed Google Scholar
• Ward, L. D. & Kellis, M. Evidence of abundant purifying selection in humans for recently acquired regulatory functions. Science 337, 1675–1678 (2012).
  CAS PubMed PubMed Central Google Scholar
• Visel, A., Minovitsky, S., Dubchak, I. & Pennacchio, L. A. VISTA Enhancer Browser — a database of tissue-specific human enhancers. Nucleic Acids Res. 35, D88–D92 (2007).
  CAS PubMed Google Scholar
• Weinhold, N., Jacobsen, A., Schultz, N., Sander, C. & Lee, W. Genome-wide analysis of noncoding regulatory mutations in cancer. Nat. Genet. 46, 1160–1165 (2014). Analysis of hundreds of cancer whole-genomes to identify driver mutations in non-coding regions.
  CAS PubMed PubMed Central Google Scholar
• Fredriksson, N. J., Ny, L., Nilsson, J. A. & Larsson, E. Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. Nat. Genet. 46, 1258–1263 (2014).
  CAS PubMed Google Scholar
• Smith, K. S. et al. Signatures of accelerated somatic evolution in gene promoters in multiple cancer types. Nucleic Acids Res. 43, 5307–5317 (2015).
  CAS PubMed PubMed Central Google Scholar
• Melton, C., Reuter, J. A., Spacek, D. V. & Snyder, M. Recurrent somatic mutations in regulatory regions of human cancer genomes. Nat. Genet. 47, 710–716 (2015).
  CAS PubMed PubMed Central Google Scholar
• Katainen, R. et al. CTCF/cohesin-binding sites are frequently mutated in cancer. Nat. Genet. 47, 818–821 (2015).
  CAS PubMed Google Scholar
• Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519–524 (2015).
  CAS PubMed Google Scholar
• Treangen, T. J. & Salzberg, S. L. Repetitive DNA and next-generation sequencing: computational challenges and solutions. Nat. Rev. Genet. 13, 36–46 (2012).
  CAS Google Scholar
• Mijuškovic´, M. et al. A streamlined method for detecting structural variants in cancer genomes by short read paired-end sequencing. PLoS ONE 7, e48314 (2012).
  PubMed PubMed Central Google Scholar
• Meyerson, M., Gabriel, S. & Getz, G. Advances in understanding cancer genomes through second-generation sequencing. Nat. Rev. Genet. 11, 685–696 (2010).
  CAS PubMed Google Scholar
• Heidenreich, B., Rachakonda, P. S., Hemminki, K. & Kumar, R. TERT promoter mutations in cancer development. Curr. Opin. Genet. Dev. 24, 30–37 (2014).
  CAS PubMed Google Scholar
• Huang, F. W. et al. Highly recurrent TERT promoter mutations in human melanoma. Science 339, 957–959 (2013). One of the first papers showing prevalence of TERT promoter mutations in cancer.
  CAS PubMed PubMed Central Google Scholar
• Killela, P. J. et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc. Natl Acad. Sci. USA 110, 6021–6026 (2013).
  CAS PubMed Google Scholar
• Hnisz, D. et al. Super-enhancers in the control of cell identity and disease. Cell 155, 934–947 (2013).
  CAS PubMed Google Scholar
• Mansour, M. R. et al. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element. Science 346, 644–648 (2014).
  Google Scholar
• Tomlins, S. A. et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310, 1373–1377 (2005).
  Google Scholar
• Yu, J. et al. An integrated network of androgen receptor, polycomb, and TMPRSS2_−_ERG gene fusions in prostate cancer progression. Cancer Cell 17, 443–454 (2010).
  CAS PubMed PubMed Central Google Scholar
• Berger, M. F. et al. The genomic complexity of primary human prostate cancer. Nature 470, 214–220 (2011).
  CAS PubMed PubMed Central Google Scholar
• Weischenfeldt, J. et al. Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer. Cancer Cell 23, 159–170 (2013).
  CAS PubMed Google Scholar
• Northcott, P. A. et al. Enhancer hijacking activates GFI1 family oncogenes in medulloblastoma. Nature 511, 428–434 (2014).
  CAS PubMed PubMed Central Google Scholar
• Breit, T. M. et al. Site-specific deletions involving the _tal_-1 and sil genes are restricted to cells of the T cell receptor α/β lineage: T cell receptor δ gene deletion mechanism affects multiple genes. J. Exp. Med. 177, 965–977 (1993).
  CAS PubMed Google Scholar
• Nambiar, M., Kari, V. & Raghavan, S. C. Chromosomal translocations in cancer. Biochim. Biophys. Acta 1786, 139–152 (2008).
  CAS PubMed Google Scholar
• Gutschner, T. & Diederichs, S. The hallmarks of cancer: a long non-coding RNA point of view. RNA Biol. 9, 703–719 (2012).
  CAS PubMed PubMed Central Google Scholar
• Han, Y., Liu, Y., Nie, L., Gui, Y. & Cai, Z. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology 81, 209.e1–209.e7 (2013).
  Google Scholar
• Liu, P. Y. et al. Effects of a novel long noncoding RNA, lncUSMycN, on N-Myc expression and neuroblastoma progression. J. Natl Cancer Inst. 106, dju113 (2014).
  PubMed Google Scholar
• Buechner, J. & Einvik, C. N-myc and noncoding RNAs in neuroblastoma. Mol. Cancer Res. 10, 1243–1253 (2012).
  CAS PubMed Google Scholar
• Lin, P. C. et al. Epigenetic repression of miR-31 disrupts androgen receptor homeostasis and contributes to prostate cancer progression. Cancer Res. 73, 1232–1244 (2013).
  CAS PubMed Google Scholar
• Poliseno, L. et al. A coding-independent function of gene and pseudogene mRNAs regulates tumour biology. Nature 465, 1033–1038 (2010).
  CAS PubMed PubMed Central Google Scholar
• Karreth, F. A. et al. The BRAF pseudogene functions as a competitive endogenous RNA and induces lymphoma in vivo. Cell 161, 319–332 (2015).
  CAS PubMed Google Scholar
• Bahcall, O. G. iCOGS collection provides a collaborative model. Nat. Genet. 45, 343 (2013).
  CAS PubMed Google Scholar
• MacArthur, D. G. et al. A systematic survey of loss-of-function variants in human protein-coding genes. Science 335, 823–828 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wang, Q., Lu, Q. & Zhao, H. A review of study designs and statistical methods for genomic epidemiology studies using next generation sequencing. Front. Genet. 6, 149 (2015).
  PubMed PubMed Central Google Scholar
• Bond, G. L. & Levine, A. J. A single nucleotide polymorphism in the p53 pathway interacts with gender, environmental stresses and tumor genetics to influence cancer in humans. Oncogene 26, 1317–1323 (2007).
  CAS PubMed Google Scholar
• Bond, G. L. et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119, 591–602 (2004).
  CAS PubMed Google Scholar
• Grisanzio, C. & Freedman, M. L. Chromosome 8q24-associated cancers and MYC. Genes Cancer 1, 555–559 (2010).
  CAS PubMed PubMed Central Google Scholar
• Huang, Q. et al. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. Nat. Genet. 46, 126–135 (2014).
  CAS PubMed Google Scholar
• Oldridge, D. A. et al. Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism. Nature 528, 418–421 (2015).
  CAS PubMed PubMed Central Google Scholar
• Garritano, S. et al. In-silico identification and functional validation of allele-dependent AR enhancers. Oncotarget 6, 4816–4828 (2015).
  PubMed PubMed Central Google Scholar
• Bakker, J. L. et al. A novel splice site mutation in the noncoding region of BRCA2: implications for Fanconi anemia and familial breast cancer diagnostics. Hum. Mut. 35, 442–446 (2014).
  CAS PubMed Google Scholar
• Demichelis, F. et al. Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk. Proc. Natl Acad. Sci. USA 109, 6686–6691 (2012).
  CAS PubMed Google Scholar
• Chen, X. et al. Targeted resequencing of the microRNAome and 3′UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer. Oncogene 34, 2125–2137 (2015).
  CAS PubMed Google Scholar
• Yang, Q. et al. Genetic variations in miR-27a gene decrease mature miR-27a level and reduce gastric cancer susceptibility. Oncogene 33, 193–202 (2014).
  CAS PubMed Google Scholar
• Chu, M. C., Selam, F. B. & Taylor, H. S. HOXA10 regulates p53 expression and matrigel invasion in human breast cancer cells. Cancer Biol. Ther. 3, 568–572 (2004).
  CAS PubMed Google Scholar
• Li, Q. et al. Integrative eQTL-based analyses reveal the biology of breast cancer risk loci. Cell 152, 633–641 (2013).
  CAS PubMed PubMed Central Google Scholar
• Xu, X. et al. Variants at IRX4 as prostate cancer expression quantitative trait loci. Eur. J. Hum. Genet. 22, 558–563 (2014).
  CAS PubMed Google Scholar
• Ongen, H. et al. Putative _cis_-regulatory drivers in colorectal cancer. Nature http://dx.doi.org/10.1038/nature13602 (2014).
• Knudson, A. G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl Acad. Sci. USA 68, 820–823 (1971).
  PubMed Google Scholar
• Calin, G. A. et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc. Natl Acad. Sci. USA 101, 2999–3004 (2004).
  CAS PubMed Google Scholar
• Pasic, I. et al. Recurrent focal copy-number changes and loss of heterozygosity implicate two noncoding RNAs and one tumor suppressor gene at chromosome 3q13.31 in osteosarcoma. Cancer Res. 70, 160–171 (2010).
  CAS PubMed Google Scholar
• Liu, Q. et al. LncRNA loc285194 is a p53-regulated tumor suppressor. Nucleic Acids Res. 41, 4976–4987 (2013).
  CAS PubMed PubMed Central Google Scholar
• Rachakonda, P. S. et al. TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism. Proc. Natl Acad. Sci. USA 110, 17426–17431 (2013).
  CAS PubMed Google Scholar
• Gnad, F., Baucom, A., Mukhyala, K., Manning, G. & Zhang, Z. Assessment of computational methods for predicting the effects of missense mutations in human cancers. BMC Genomics 14, S7 (2013).
  PubMed PubMed Central Google Scholar
• Lee, S. et al. Optimal unified approach for rare-variant association testing with application to small-sample case−control whole-exome sequencing studies. Am. J. Hum. Genet. 91, 224–237 (2012).
  CAS PubMed PubMed Central Google Scholar
• Tamborero, D. et al. Comprehensive identification of mutational cancer driver genes across 12 tumor types. Sci. Rep. 3, 2650 (2013).
  PubMed PubMed Central Google Scholar
• Lochovsky, L., Zhang, J., Fu, Y., Khurana, E. & Gerstein, M. LARVA: an integrative framework for large-scale analysis of recurrent variants in noncoding annotations. Nucleic Acids Res. 43, 8123–8134 (2015). Method that accounts for heterogeneity in mutation rate in non-coding regions to identify regulatory driver mutations.
  CAS PubMed PubMed Central Google Scholar
• Ng, P. C. & Henikoff, S. SIFT: predicting amino acid changes that affect protein function. Nucleic Acids Res. 31, 3812–3814 (2003).
  CAS PubMed PubMed Central Google Scholar
• Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat. Methods 7, 248–249 (2010).
  CAS PubMed PubMed Central Google Scholar
• Polak, P. et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518, 360–364 (2015). Shows that somatic mutation density can be predicted based on epigenomic features from the cell of origin.
  CAS PubMed PubMed Central Google Scholar
• Fu, Y. et al. FunSeq2: a framework for prioritizing noncoding regulatory variants in cancer. Genome Biol. 15, 480 (2014).
  PubMed PubMed Central Google Scholar
• O'Roak, B. J. et al. Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders. Science 41, 177–181 (2012).
  Google Scholar
• Konermann, S. et al. Genome-scale transcriptional activation by an engineered CRISPR−Cas9 complex. Nature 517, 583–588 (2014).
  PubMed PubMed Central Google Scholar
• Mogno, I., Kwasnieski, J. C. & Cohen, B. A. Massively parallel synthetic promoter assays reveal the in vivo effects of binding site variants. Genome Res. 23, 1908–1915 (2013).
  CAS PubMed PubMed Central Google Scholar
• Arnold, C. D. et al. Genome-wide quantitative enhancer activity maps identified by STARR-seq. Science 339, 1074–1077 (2013).
  CAS PubMed Google Scholar
• Melnikov, A. et al. Systematic dissection and optimization of inducible enhancers in human cells using a massively parallel reporter assay. Nat. Biotechnol. 30, 271–277 (2012).
  CAS PubMed PubMed Central Google Scholar
• Shlyueva, D., Stampfel, G. & Stark, A. Transcriptional enhancers: from properties to genome-wide predictions. Nat. Rev. Genet. 15, 272–286 (2014).
  CAS PubMed Google Scholar
• Kwasnieski, J. C., Fiore, C., Chaudhari, H. G. & Cohen, B. A. High-throughput functional testing of ENCODE segmentation predictions. Genome Res. 24, 1595–1602 (2014).
  CAS PubMed PubMed Central Google Scholar
• Singh, G. & Cooper, T. A. Minigene reporter for identification and analysis of cis elements and trans factors affecting pre-mRNA splicing. Biotechniques 41, 177–181 (2006).
  CAS PubMed Google Scholar
• Gaildrat, P. et al. Use of splicing reporter minigene assay to evaluate the effect on splicing of unclassified genetic variants. Methods Mol. Biol. 653, 249–257 (2010).
  CAS PubMed Google Scholar
• Poulos, R. C. et al. Systematic screening of promoter regions pinpoints functional _cis_-regulatory mutations in a cutaneous melanoma genome. Mol. Cancer Res. 13, 1218–1226 (2015).
  CAS PubMed Google Scholar
• van de Wetering, M. et al. Prospective derivation of a living organoid biobank of colorectal cancer patients. Cell 161, 933–945 (2015).
  CAS PubMed PubMed Central Google Scholar
• Boj, S. F. et al. Organoid models of human and mouse ductal pancreatic cancer. Cell 160, 324–338 (2015).
  CAS PubMed Google Scholar
• Gao, D. et al. Organoid cultures derived from patients with advanced prostate cancer. Cell 159, 176–187 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ermann, J. & Glimcher, L. H. After GWAS: mice to the rescue? Curr. Opin. Immunol. 24, 564–570 (2012).
  CAS PubMed PubMed Central Google Scholar
• Seruggia, D., Fernández, A., Cantero, M., Pelczar, P. & Montoliu, L. Functional validation of mouse tyrosinase non-coding regulatory DNA elements by CRISPR−Cas9-mediated mutagenesis. Nucleic Acids Res. 43, 4855–4867 (2015).
  CAS PubMed PubMed Central Google Scholar
• Mou, H., Kennedy, Z., Anderson, D. G., Yin, H. & Xue, W. Precision cancer mouse models through genome editing with CRISPR−Cas9. Genome Med. 7, 53 (2015).
  PubMed PubMed Central Google Scholar
• Vogelstein, B. et al. Cancer genome landscapes. Science 339, 1546–1558 (2013).
  CAS PubMed PubMed Central Google Scholar
• The Cancer Genome Atlas Research Network. Comprehensive molecular profiling of lung adenocarcinoma. Nature 511, 543–550 (2014).
• Guenther, C. A., Tasic, B., Luo, L., Bedell, M. A. & Kingsley, D. M. A molecular basis for classic blond hair color in Europeans. Nat. Genet. 46, 748–752 (2014).
  CAS PubMed PubMed Central Google Scholar
• Davoli, T. et al. Cumulative haploinsufficiency and triplosensitivity drive aneuploidy patterns and shape the cancer genome. Cell 155, 948–962 (2013).
  CAS PubMed PubMed Central Google Scholar
• Xue, W. et al. A cluster of cooperating tumor-suppressor gene candidates in chromosomal deletions. Proc. Natl Acad. Sci. USA 109, 8212–8217 (2012).
  CAS PubMed Google Scholar
• Wang, K. et al. Whole-genome sequencing and comprehensive molecular profiling identify new driver mutations in gastric cancer. Nat. Genet. 46, 573–582 (2014).
  CAS PubMed Google Scholar
• Thurman, R. E. et al. The accessible chromatin landscape of the human genome. Nature 489, 75–82 (2012).
  CAS PubMed PubMed Central Google Scholar
• Bush, W. S. & Moore, J. H. Chapter 11: genome-wide association studies. PLoS Comput. Biol. 8, e1002822 (2012).
  CAS PubMed PubMed Central Google Scholar
• Chelala, C., Khan, A. & Lemoine, N. R. SNPnexus: a web database for functional annotation of newly discovered and public domain single nucleotide polymorphisms. Bioinformatics 25, 655–661 (2009).
  CAS PubMed Google Scholar
• Dayem Ullah, A. Z., Lemoine, N. R. & Chelala, C. SNPnexus: a web server for functional annotation of novel and publicly known genetic variants (2012 update). Nucleic Acids Res. 40, W65–W70 (2012).
  CAS PubMed PubMed Central Google Scholar
• Wang, K., Li, M. & Hakonarson, H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).
  PubMed PubMed Central Google Scholar
• McLaren, W. et al. Deriving the consequences of genomic variants with the Ensembl API and SNP Effect Predictor. Bioinformatics 26, 2069–2070 (2010).
  CAS PubMed PubMed Central Google Scholar
• Perera, D. et al. OncoCis: annotation of _cis_-regulatory mutations in cancer. Genome Biol. 15, 485 (2014).
  PubMed PubMed Central Google Scholar
• Paila, U., Chapman, B. A., Kirchner, R. & Quinlan, A. R. GEMINI: integrative exploration of genetic variation and genome annotations. PLoS Comput. Biol. 9, e1003153 (2013).
  CAS PubMed PubMed Central Google Scholar
• Coetzee, S. G., Rhie, S. K., Berman, B. P., Coetzee, G. A. & Noushmehr, H. FunciSNP: an R/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs. Nucleic Acids Res. 40, e139 (2012).
  CAS PubMed PubMed Central Google Scholar
• Ward, L. D. & Kellis, M. HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res. 40, D930–D934 (2012).
  CAS PubMed Google Scholar
• Li, M. J., Wang, L. Y., Xia, Z., Sham, P. C. & Wang, J. GWAS3D: detecting human regulatory variants by integrative analysis of genome-wide associations, chromosome interactions and histone modifications. Nucleic Acids Res. 41, W150–W158 (2013).
  PubMed PubMed Central Google Scholar
• Macintyre, G., Bailey, J., Haviv, I. & Kowalczyk, A. is-rSNP: a novel technique for in silico regulatory SNP detection. Bioinformatics 26, i524–i530 (2010).
  CAS PubMed PubMed Central Google Scholar
• Boyle, A. P. et al. Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 22, 1790–1797 (2012).
  CAS PubMed PubMed Central Google Scholar
• Lehmann, K. V. & Chen, T. Exploring functional variant discovery in non-coding regions with SInBaD. Nucleic Acids Res. 41, e7 (2013).
  CAS PubMed Google Scholar
• Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310–315 (2014).
  CAS PubMed PubMed Central Google Scholar
• Ritchie, G. R., Dunham, I., Zeggini, E. & Flicek, P. Functional annotation of noncoding sequence variants. Nat. Methods 11, 294–296 (2014).
  CAS PubMed PubMed Central Google Scholar
• Gulko, B., Hubisz, M. J., Gronau, I. & Siepel, A. A method for calculating probabilities of fitness consequences for point mutations across the human genome. Nat. Genet. 47, 276–283 (2015).
  CAS PubMed PubMed Central Google Scholar
• Zhou, J. & Troyanskaya, O. G. Predicting effects of noncoding variants with deep learning-based sequence model. Nat. Methods 12, 931–934 (2015).
  CAS PubMed PubMed Central Google Scholar